Novogenia AG (MUN:7V0)
Germany · Delayed Price · Currency is EUR 5.80
-0.70 (-10.77%)
At close: Aug 19, 2026
Novogenia AG Market Cap
Novogenia AG has a market cap or net worth of €69.6 million as of August 26, 2026. Its market cap has decreased by -12.12% in one year.
Market Cap
69.60M
Enterprise Value
22.73M
Revenue
54.30M
Ranking
n/a
PE Ratio
127.60
Stock Price
€5.80
ChartMarket Cap Chart
Since November 2, 2021, Novogenia AG's market cap has increased from 21.30M to 69.60M, an increase of 226.76%. That is a compound annual growth rate of 27.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 69.60M | -25.16% |
| Dec 22, 2025 | 93.00M | -14.36% |
| Dec 29, 2023 | 108.60M | -21.30% |
| Dec 30, 2022 | 138.00M | 88.52% |
| Dec 13, 2021 | 73.20M | 243.66% |
| Nov 2, 2021 | 21.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 22.04M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 231.09K |
| MagForce AG | 91.72K |